Identification of neoadjuvant chemoradiotherapy resistance-associated proteins in locally advanced rectal cancer: A pilot study
Jiang-Yi He, Yan Dong, Can Chen, Fang-Hao Lu, Feng-Wei Ran, Qiong Ding, Yun Du, Tao-Rui Liu, Yu-Ying Zhang, Teng Wang, Yu-Han Chen, Xiang Zhao, Sen-Lin Xu, Jian-Jun Li · 2026
Read Identification of neoadjuvant chemoradiotherapy resistance-associated proteins in locally advanced rectal cancer: A pilot study by Jiang-Yi He, Yan Dong, Can Chen, Fang-Hao Lu, Feng-Wei Ran, Qiong Ding, Yun Du, Tao-Rui Liu, Yu-Ying Zhang, Teng Wang, Yu-Han Chen, Xiang Zhao, Sen-Lin Xu, Jian-Jun Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13324575.txt.
Description
Jiang-Yi He and co-authors hunt proteins tied to treatment resistance in rectal cancer in a 2026 pilot study. Chemotherapy plus radiation before surgery fails some patients with locally advanced disease, and those patients fare worse.
Mass spectrometry read 6,006 proteins in tumor samples from four resistant and four sensitive cases, taken before and after treatment. Resistant tumors held 133 extra proteins before therapy and 290 after, linked to cell junctions, DNA work, and metabolism. Cross-checks with public data singled out BCKDHA as a lead candidate. In tissue arrays, high BCKDHA meant shorter survival, and in cells it blunted radiation damage. Larger studies must confirm the signal.
Catalog record
| CREATOR | Jiang-Yi He, Yan Dong, Can Chen, Fang-Hao Lu, Feng-Wei Ran, Qiong Ding, Yun Du, Tao-Rui Liu, Yu-Ying Zhang, Teng Wang, Yu-Han Chen, Xiang Zhao, Sen-Lin Xu, Jian-Jun Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38220 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |